- Details
- Description
Packaging Size:
28 film-coated tablets (EU); US packaging also includes 30- and 90-tablet bottles
Strength:
80 mg
Composition:
Each tablet contains resmetirom 80 mg. Excipients include microcrystalline cellulose, mannitol, croscarmellose sodium, colloidal anhydrous silica, and magnesium stearate; coating includes polyvinyl alcohol, titanium dioxide, macrogol, talc, and yellow iron oxide
Treatment:
Used with diet and exercise for adults with non-cirrhotic MASH/NASH with moderate-to-advanced liver fibrosis (F2–F3).
Form:
Film-coated tablet for oral use
Brand:
Rezdiffra®
Quantity Unit:
Tablets
Manufacturer:
Corden Pharma GmbH, Germany (EU product); marketing authorization holder: Madrigal Pharmaceuticals EU Limited
Resiliva 80 mg is a prescription oral medicine containing resmetirom, a thyroid hormone receptor-beta (THR-β) agonist. It is used with diet and exercise for the treatment of adults with noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH/NASH) with moderate to advanced liver fibrosis (F2–F3). Resiliva 80 contains 80 mg of resmetirom per tablet and is taken once daily as prescribed by a healthcare professional.
Manufacturer address: Everest Pharmaceuticals Ltd., BSCIC I/A, Kawchar, Narayanganj, Bangladesh.
Packaging: The manufacturer's prescribing information specifies 30 film-coated tablets in an HDPE container with a silica-gel desiccant and child-resistant closure
